Skip to main content

Table 3 Characteristics of the NMR metabotypes

From: Associations between dietary intake and glucose tolerance in clinical and metabolomics-based metabotypes

 

Favorable NMR metabotype (n = 127)*

Unfavorable NMR metabotype (n = 76)**

n (%)

 Men

30 (23.6)

40 (52.6)

 Statin users

22 (17.3)

7 (9.2)

 Anti-inflammatory drug users

7 (5.5)

0 (0)

 Premenopausal women

54 (56)

12 (33)

 Women using hormonal contraceptives

29 (30)

3 (8)

Mean (SD)

 Age (years)

49 (13)

51 (11)

 BMI (kg/m2)

31.8 (5.1)

32.7 (4.9)

 Waist circumference (cm)

105.0 (14.5)

109.6 (12.8)

 HbA1c (mmol/mol)

29 (15)

32 (16)

 Total-C (mmol/L)

4.6 (0.8)

5.7 (0.9)

 LDL-C (mmol/L)

3.0 (0.7)

4.1 (0.9)

 Median (IQR)

 HDL-C (mmol/L)

1.4 (0.5)

1.1 (0.3)

 Triglycerides (mmol/L)

1.06 (0.45)

1.9 (0.99)

 Lp(a) (mg/L)

309 (531)

227 (341)

 Fasting glucose (mmol/L)

5.1 (0.9)

5.5 (0.9)

 Insulin (pmol/L)

68 (59)

96 (71)

 2-h glucose (mmol/L)

5.1 (2.2)

5.8 (2.5)

 Systolic BP (mmHg)

117 (18)

123 (17)

 Diastolic BP (mmHg)

70 (12)

73 (14)

 CRP (mg/L)

2.5 (3.7)

3.3 (4.8)

  1. *Age, n = 125; BMI, waist circumference, 2 h glucose, systolic and diastolic blood pressure, n = 126; Lp(a), n = 67
  2. **Age, LDL-c, HDL-C, n = 74; BMI and 2-h glucose, n = 75; Lp(a), n = 49
  3. BMI, body mass index, HbA1c, glycated hemoglobin, C, cholesterol, LDL, low-density lipoprotein, HDL, high-density lipoprotein, Lp(a), lipoprotein a, BP, blood pressure, CRP, C-reactive protein